Vs. Trubetskoy et al., MASSAGE-INDUCED RELEASE OF SUBCUTANEOUSLY INJECTED LIPOSOME-ENCAPSULATED DRUGS TO THE BLOOD, Journal of controlled release, 50(1-3), 1998, pp. 13-19
Liposome-based, externally regulated drug delivery system is described
in which liposome-encapsulated bioactive molecules can be delivered i
nto the blood in response to simple mechanical action. Without any mec
hanical stimulation, subcutaneously injected 200 nm liposomes are usua
lly trapped in the interstitial space for prolonged time. However, upo
n lymphotropic stimulation (such as manual massage of the injection si
te), the liposomes can be mobilized into the blood via lymphatic pathw
ay. Up to 40% of the injected dose can be delivered to the blood via l
ymphatic pathway from the injection site at the rabbit's front paw dor
sum during 5 min manual massage cycle. Using vasoconstricting hormone
angiotensin II as liposome-encapsulated pharmacological marker, we dem
onstrated that physiological response to encapsulated drug (average bl
ood pressure increase) can also be induced and modulated by massage. M
assage itself was found to have no effect on the blood pressure. Modif
ication of liposome surface with polyethylene glycol was found to incr
ease blood localization of the liposome-encapsulated drug presumably d
ue to decreasing the uptake of the drug carrier by lymph node macropha
ges. Pressure-dependent gaps between lymphatic capillary endothelial c
ells are thought to play the role of the size discrimination device al
lowing larger particulates into the lymphatics and, eventually, into t
he blood after increase of interstitial pressure caused by injection s
ite massage. (C) 1998 Elsevier Science B.V.